UPDATE: Morgan Stanley Initiates Zoetis at Equal-Weight; Fundamentals Reflect Balanced Risk/Reward


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Morgan Stanley initiated coverage on Zoetis (NYSE: ZTS) with an Equal-weight rating.Morgan Stanley analyst David Risinger commented, "ZTS is a global leader in animal health, and we expect mgmt. to deliver mid-teens EPS growth over the next several years. However, ZTS shares are up 30% (vs. S&P +4%) since IPO on Feb. 1, and we see a balanced risk reward at 24x our 2013E EPS. […] At 24x our 2013E EPS of $1.41 (20x 2014E EPS) and 16x our ‘13E EBITDA (14x 2014E EBITDA), ZTS trades at a premium to Large-Cap Growth companies like Monsanto, Mead Johnson, and Perrigo as well as SMID-Cap Animal Health companies like Idexx, VCA, and Virbac. Given ZTS's premium multiple on EPS and EBITDA, we think material EPS upside is required to drive stock outperformance."Zoetis closed at $34.18 on Tuesday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorInitiationAnalyst RatingsMorgan Stanley